In the fourth reprise of our recently launched Complimentary Exclusive Video Interview, we have Rashmi Gurnani CEO of AKT Health Analytics. Rashmi sheds light on AKT’s distributor partnership with Certara, known for delivering global drug development solutions to pharmaceutical companies and CROs. While discussing AKT’s role in assisting the US clients with Japan’s PMDA’s approval,…
Introducing the third installment of our recently launched Complimentary Exclusive Video Interview. Jonathan Usuka, Chief Business Officer at Sapient, highlighted Sapient’s high throughput proteomics and metabolomics capabilities to generate multi-omics data and the analytical power to transcend the genome to achieve robust biological discoveries in expediting clinical studies.By leveraging Sapient's real-world data asset, the…
In the second reprise of our Complimentary Exclusive Video Interview, we had the pleasure to speak with Nick Kadysh, the Founding CEO and President of PharmAla Biotech. Our complimentary exclusive video interview is an initiative to voice the global biopharma leaders by offering them a platform to shed light on the developments in the healthcare…
Knowledge-packed, informative, and engaging, the Reuters Pharma 2024 event brimmed with enlightening sessions, presentations, and scientific orators shedding light on innovative therapies and unmet needs of the healthcare sector. Day 1 commenced with keynote speakers shedding light on next-generation customer engagement models, mastering patient-centric metrics, amplifying strategic voice, and expediting equitable access followed by a…
With great zeal, PharmaShots began an Exclusive Video Interview series for C-suites. An innovative idea to bring thought leaders of the industry, our Exclusive Video Interview offering is a noble initiative by PharmaShots to capture the developments of leading companies. As a part of offering, PharmaShots will be publishing exclusive video interviews every second Monday…
Following the Reuters Events Pharma USA 2024, PharmaShots brings an engaging conversation with Moreno Perugini, President, of Néstle Health Science. Moreno begins the conversation by highlighting Néstle’s journey to become a full-fledged pharma company through a series of acquisitions and deals. Moreno recalls Néstle’s transitioning into a pharmaceutical company when the company got the rights for Zenpep,…
Inspiring, innovating, and trailing, the Pharma USA 2024 by Reuters Events witnessed an exceptional and exemplary gathering from the biopharmaceutical, healthcare, and tech companies. The two-day event remained the talk of the town in the healthcare fraternity, and your favorite media house PharmaShots, as a media partner was there in person to provide a panoptic…
Shots: Our recent Spotlight interview with David Esposito, CEO at ONL therapeutics became a major hit on the internet. We were moved by the overwhelming response from the netizens Here we have again, David Esposito in an engaging conversation with PharmaShots. David discusses in great length about the company’s lead candidate ONL1204, currently being evaluated…
Shots: In an extended cut to our Spotlight Interview, PharmaShots presents an exclusive interview session with David A. Dodd, Chairman, President, and CEO at GeoVax labs David speaks about the company’s rich history and highlights the journey through the years and the strategic shift from being a single-focus HIV vaccine developing company to an infectious…
Spotlight Interview: David A. Dodd, CEO at GeoVax Labs, in an Engaging Conversation with PharmaShots
PharmaShots’ Spotlight offers a unique platform for biopharma, life sciences, and healthcare companies, allowing them to connect with their target audiences and like-minded people. This week at the Spotlight, we had a riveting discussion with David A. Dodd, Chairman, President & CEO, at GeoVax Labs. David eloquently highlighted GeoVax’s extraordinary journey over the years from…

